WallStreetZenWallStreetZen

NASDAQ: BNGO
Bionano Genomics Inc Earnings & Revenue

BNGO past revenue growth

How has BNGO's revenue growth performed historically?
Company
26.93%
Industry
8.17%
Market
19.67%
BNGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BNGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BNGO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BNGO earnings and revenue history

Current Revenue
$37.5M
Current Earnings
-$226.8M
Current Profit Margin
-605.3%

BNGO Return on Equity

Current Company
-176.9%
Current Industry
11.3%
Current Market
28.2%
BNGO's Return on Equity (-176.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BNGO announces earnings.

BNGO Return on Assets

Current Company
-109.9%
Current Industry
7.7%
BNGO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BNGO Return on Capital Employed

Current Company
-222.75%
Current Industry
10.1%
BNGO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNGO vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BNGO$37.47M-$207.91M-$226.79M+25.40%N/A
MLSS$9.48M-$7.09M-$7.06M-0.53%N/A
PDEX$49.46M$7.57M$4.35M+13.36%+8.71%
POCI$19.41M-$1.20M-$1.64M+26.96%N/A
RVP$40.20M-$2.00M-$7.80M+3.69%N/A

BNGO earnings dates

Next earnings date
Aug 7, 2024

Bionano Genomics Earnings & Revenue FAQ

What were BNGO's earnings last quarter?

On Invalid Date, Bionano Genomics (NASDAQ: BNGO) reported Q1 2024 earnings per share (EPS) of -$0.60, up 51.22% year over year. Total Bionano Genomics earnings for the quarter were -$31.42 million. In the same quarter last year, Bionano Genomics's earnings per share (EPS) was -$1.23.

If you're new to stock investing, here's how to buy Bionano Genomics stock.

What was BNGO's earnings growth in the past year?

As of Q2 2024, Bionano Genomics's earnings has grown year over year. Bionano Genomics's earnings in the past year totalled -$226.79 million.

What is BNGO's earnings date?

Bionano Genomics's earnings date is Invalid Date. Add BNGO to your watchlist to be reminded of BNGO's next earnings announcement.

What was BNGO's revenue last quarter?

On Invalid Date, Bionano Genomics (NASDAQ: BNGO) reported Q1 2024 revenue of $8.77 million up 18.26% year over year. In the same quarter last year, Bionano Genomics's revenue was $7.42 million.

What was BNGO's revenue growth in the past year?

As of Q2 2024, Bionano Genomics's revenue has grown 26.93% year over year. This is 18.76 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 8.17%. Bionano Genomics's revenue in the past year totalled $37.47 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.